|
ZNF542 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
5.16270000083807E-08 |
| Normal-vs-Stage3 |
2.92680000235634E-08 |
| Normal-vs-Stage4 |
4.36310000000439E-05 |
| Stage1-vs-Stage2 |
2.463400E-01 |
| Stage1-vs-Stage3 |
6.160600E-01 |
| Stage1-vs-Stage4 |
1.737350E-01 |
| Stage2-vs-Stage3 |
5.702400E-01 |
| Stage2-vs-Stage4 |
6.612400E-01 |
| Stage3-vs-Stage4 |
3.805800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
8.88467077686528E-12 |
| Normal-vs-Asian |
1.60981999999255E-05 |
| Caucasian-vs-AfricanAmerican |
9.640000E-02 |
| Caucasian-vs-Asian |
7.974600E-01 |
| AfricanAmerican-vs-Asian |
7.423000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
2.42819986340237E-10 |
| Male-vs-Female |
8.120100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.66310307139861E-11 |
| Normal-vs-Extreme_Weight |
<1E-12 |
| Normal-vs-Obese |
3.06989988985151E-11 |
| Normal-vs-Extreme_Obese |
1.564510E-03 |
| Normal_Weight-vs-Extreme_Weight |
3.651200E-01 |
| Normal_Weight-vs-Obese |
5.754200E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.772000E-01 |
| Extreme_Weight-vs-Obese |
1.054620E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.322000E-01 |
| Obese-vs-Extreme_Obese |
3.995000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.000800E-03 |
| Normal-vs-Age(41-60Yrs) |
9.99200722162641E-16 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
3.73423514332671E-12 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.221000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.225900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.796400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.070100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.114400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.849970E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
<1E-12 |
| Normal-VS-Type2 PRCC |
1.62447832963153E-12 |
| Normal-VS-KIRP CIMP |
4.017000E-01 |
| Normal-VS-Unclassified PRCC |
1.37549971412909E-10 |
| Type1 PRCC-VS-Type2 PRCC |
4.28060000000619E-05 |
| Type1 PRCC-VS-KIRP CIMP |
1.295780E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
3.111800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.41559999999874E-06 |
| Type2 PRCC-VS-Unclassified PRCC |
5.897600E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.175800E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62436730732907E-12 |
| Normal-vs-N1 |
2.87070000004608E-06 |
| Normal-vs-N2 |
5.159500E-02 |
| N0-vs-N1 |
4.955400E-01 |
| N0-vs-N2 |
8.916800E-01 |
| N1-vs-N2 |
7.014600E-01 |
|
|
